SCHEMBL15965641

SCHEMBL15965641

CCCN[C@@H](CCCCN)C(=O)CC

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SIRT6 Q8N6T7 1/20 0.46
▸ SIRT1 Q96EB6 1/20 0.46
▸ GNAI3 P08754 1/20 0.43
▸ GNAO1 P09471 1/20 0.43
▸ GNAI1 P63096 1/20 0.43
▸ TLR2 O60603 3/20 0.41
▸ SLC6A5 Q9Y345 1/20 0.39
▸ FOLH1 Q04609 1/20 0.38
▸ DPP7 Q9UHL4 2/20 0.37
▸ DPP8 Q6V1X1 1/20 0.37
▸ DPP9 Q86TI2 1/20 0.37
▸ CPB2 Q96IY4 2/20 0.36
▸ GSR P00390 1/20 0.36
▸ PAOX Q6QHF9 2/20 0.35
▸ RNPEP Q9H4A4 1/20 0.35
▸ RRM1 P23921 1/20 0.35
▸ FURIN P09958 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10073549 0.86 FOLH1 (0.44) SIRT6SIRT1GNAI3GNAO1GNAI1
SCHEMBL18882588 0.86 FOLH1 (0.44) SIRT6SIRT1GNAI3GNAO1GNAI1
SCHEMBL5023570 0.84 FOLH1 (0.50) SIRT6SIRT1GNAI3GNAO1GNAI1
SCHEMBL17050165 0.84 SIRT6 (0.50) SIRT6SIRT1GNAI3GNAO1GNAI1
SCHEMBL5023568 0.84 FOLH1 (0.50) SIRT6SIRT1GNAI3GNAO1GNAI1
SCHEMBL13783657 0.83 SIRT6 (0.39) SIRT6SIRT1GNAI3GNAO1GNAI1
SCHEMBL13783659 0.83 SIRT6 (0.42) SIRT6SIRT1GNAI3GNAO1GNAI1
SCHEMBL17304948 0.80 SIRT6 (0.42) SIRT6SIRT1GNAI3GNAO1GNAI1
SCHEMBL20978516 0.80 SIRT6 (0.42) SIRT6SIRT1GNAI3GNAO1GNAI1
SCHEMBL14878853 0.80 SIRT6 (0.42) SIRT6SIRT1GNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170260580-A1 GENETIC DETECTION PLATFORM PHARMOZYME, INC. 2017-09-14 — — US disclosed
US-20140235555-A1 Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons NOVARTIS AG (CH) 2014-08-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170260580-A1 GENETIC DETECTION PLATFORM POLN, POLI, POLRMT SIRT6 4307/4885SIRT1 4846/4885GNAI3 435/4885
US-20140235555-A1 Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons PGM2, PLG, RPL7 SIRT6 2404/4885SIRT1 2344/4885GNAI3 3795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback